Display options
Cite
Cellini M, Santaguida MG, Virili C, et al. Hashimoto's Thyroiditis and Autoimmune Gastritis. Front Endocrinol (Lausanne). 2017;8:92doi: 10.3389/fendo.2017.00092.
Cellini, M., Santaguida, M. G., Virili, C., Capriello, S., Brusca, N., Gargano, L., & Centanni, M. (2017). Hashimoto's Thyroiditis and Autoimmune Gastritis. Frontiers in endocrinology, 892. https://doi.org/10.3389/fendo.2017.00092
Cellini, Miriam, et al. "Hashimoto's Thyroiditis and Autoimmune Gastritis." Frontiers in endocrinology vol. 8 (2017): 92. doi: https://doi.org/10.3389/fendo.2017.00092
Cellini M, Santaguida MG, Virili C, Capriello S, Brusca N, Gargano L, Centanni M. Hashimoto's Thyroiditis and Autoimmune Gastritis. Front Endocrinol (Lausanne). 2017 Apr 26;8:92. doi: 10.3389/fendo.2017.00092. eCollection 2017. PMID: 28491051; PMCID: PMC5405068.
Copy Download .nbib Format: NLM
Share it on

Front Endocrinol (Lausanne). 2017 Apr 26;8:92. doi: 10.3389/fendo.2017.00092. eCollection 2017.

Hashimoto's Thyroiditis and Autoimmune Gastritis.

Frontiers in endocrinology

Miriam Cellini, Maria Giulia Santaguida, Camilla Virili, Silvia Capriello, Nunzia Brusca, Lucilla Gargano, Marco Centanni

Affiliations

  1. Endocrinology Unit, Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University, Latina, Italy.

PMID: 28491051 PMCID: PMC5405068 DOI: 10.3389/fendo.2017.00092

Abstract

The term "thyrogastric syndrome" defines the association between autoimmune thyroid disease and chronic autoimmune gastritis (CAG), and it was first described in the early 1960s. More recently, this association has been included in polyglandular autoimmune syndrome type IIIb, in which autoimmune thyroiditis represents the pivotal disorder. Hashimoto's thyroiditis (HT) is the most frequent autoimmune disease, and it has been reported to be associated with gastric disorders in 10-40% of patients while about 40% of patients with autoimmune gastritis also present HT. Some intriguing similarities have been described about the pathogenic mechanism of these two disorders, involving a complex interaction among genetic, embryological, immunologic, and environmental factors. CAG is characterized by a partial or total disappearance of parietal cells implying the impairment of both hydrochloric acid and intrinsic factor production. The clinical outcome of this gastric damage is the occurrence of a hypochlorhydric-dependent iron-deficient anemia, followed by pernicious anemia concomitant with the progression to a severe gastric atrophy. Malabsorption of levothyroxine may occur as well. We have briefly summarized in this minireview the most recent achievements on this peculiar association of diseases that, in the last years, have been increasingly diagnosed.

Keywords: Helicobacter pylori infection; cellular immunity; gastric atrophy; pernicious anemia; polyglandular autoimmune syndrome; thyroiditis; thyroxine malabsorption

References

  1. Autoimmun Rev. 2015 Feb;14(2):174-80 - PubMed
  2. Clin Exp Immunol. 2011 Aug;165(2):148-54 - PubMed
  3. Dan Med J. 2016 Feb;63(2):null - PubMed
  4. Br Med J. 1963 May 25;1(5342):1374-9 - PubMed
  5. Endocrine. 2013 Feb;43(1):8-9 - PubMed
  6. Biochem J. 1995 Jan 1;305 ( Pt 1):59-64 - PubMed
  7. Gastroenterology. 2001 Feb;120(2):377-86 - PubMed
  8. World J Gastroenterol. 2014 Jan 21;20(3):613-29 - PubMed
  9. J Exp Med. 2003 Oct 20;198(8):1147-56 - PubMed
  10. Autoimmun Rev. 2016 Dec;15(12 ):1125-1128 - PubMed
  11. Expert Opin Drug Deliv. 2014 Jul;11(7):1103-11 - PubMed
  12. Blood. 2006 Feb 15;107(4):1673-9 - PubMed
  13. J Clin Endocrinol Metab. 2009 Oct;94(10):3905-12 - PubMed
  14. Best Pract Res Clin Gastroenterol. 2014 Dec;28(6):1031-42 - PubMed
  15. N Engl J Med. 2003 Jun 26;348(26):2646-55 - PubMed
  16. Scand J Gastroenterol. 2015 Jun;50(6):657-67 - PubMed
  17. World J Gastroenterol. 2008 Jan 28;14(4):563-8 - PubMed
  18. Eur J Nutr. 2007 Aug;46(5):251-6 - PubMed
  19. Clin Rev Allergy Immunol. 2012 Jun;42(3):269-78 - PubMed
  20. Thyroid. 1991 Summer;1(3):241-8 - PubMed
  21. Endocr Rev. 2014 Feb;35(1):106-49 - PubMed
  22. BMC Gastroenterol. 2016 Feb 24;16:22 - PubMed
  23. Nat Rev Gastroenterol Hepatol. 2013 Sep;10(9):529-41 - PubMed
  24. Immunol Today. 1998 Mar;19(3):121-5 - PubMed
  25. Endocr Pract. 2014 Mar;20(3):e38-41 - PubMed
  26. Clin Immunol. 2013 Dec;149(3):411-20 - PubMed
  27. Am J Med. 2008 Feb;121(2):136-41 - PubMed
  28. Horm Metab Res. 2015 Sep;47(10):702-10 - PubMed
  29. Eur J Endocrinol. 2014 Jun;170(6):R241-52 - PubMed
  30. Endocrine. 2015 May;49(1):51-7 - PubMed
  31. Aliment Pharmacol Ther. 2015 Apr;41(7):686-93 - PubMed
  32. Endocr Rev. 2002 Jun;23(3):327-64 - PubMed
  33. Autoimmunity. 2004 Jun;37(4):357-61 - PubMed
  34. J Gastric Cancer. 2013 Jun;13(2):106-10 - PubMed
  35. Autoimmun Rev. 2014 Apr-May;13(4-5):459-62 - PubMed
  36. J Clin Endocrinol Metab. 2014 Dec;99(12):4481-6 - PubMed
  37. N Engl J Med. 2006 Apr 27;354(17):1787-95 - PubMed
  38. World J Gastroenterol. 2014 Aug 14;20(30):10331-7 - PubMed
  39. Thyroid. 2010 Dec;20(12 ):1385-9 - PubMed
  40. Clin Endocrinol (Oxf). 2008 Apr;68(4):640-5 - PubMed
  41. Adv Clin Path. 2000 Jan;4(1):11-7 - PubMed
  42. J Int Med Res. 2005 Mar-Apr;33(2):222-7 - PubMed
  43. J Immunol. 2006 Jan 15;176(2):1259-65 - PubMed
  44. Arch Intern Med. 1999 Aug 9-23;159(15):1726-30 - PubMed
  45. Eur J Pharm Biopharm. 2009 May;72(1):105-10 - PubMed
  46. Endocrine. 2016 Oct;54(1):3-14 - PubMed
  47. J Clin Endocrinol Metab. 2010 Feb;95(2):953-62 - PubMed
  48. Clin Endocrinol (Oxf). 2004 Oct;61(4):405-13 - PubMed
  49. Eur J Endocrinol. 2009 Jul;161(1):11-20 - PubMed
  50. Autoimmun Rev. 2014 Apr-May;13(4-5):391-7 - PubMed

Publication Types